Greylin Investment Mangement Inc Soleno Therapeutics Inc Transaction History

Greylin Investment Mangement Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 14, 2021	SELL	$0.97 - $1.32 $79,341 - $107,969	-81,795 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$1.24 - $3.3 $38,936 - $103,620	-31,400 Reduced 27.74%	81,795 $103,000
Q4 2020 Jan 14, 2021	SELL	$1.61 - $2.23 $33,810 - $46,830	-21,000 Reduced 15.65%	113,195 $218,000
Q3 2020 Oct 13, 2020	BUY	$1.71 - $2.51 $229,473 - $336,829	134,195 New	134,195 $337,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

Stay updated on Greylin Investment Mangement Inc with notifications on news.